-
Non-Hodgkin's Lymphoma Clinical Trial Pipeline | 200+ Companies Driving Innovation to Transform Treatment
07 Feb 2025 16:47 GMT
… Tianqing Pharmaceutical Group Co., Ltd., Gilead Sciences, Acerta Pharma BV, Adagene Inc … -Hodgkin's Lymphoma Pipeline: Late-Stage Products (Phase III)
7. Non … -Hodgkin's Lymphoma Pipeline: Early Stage Products (Phase I)
10. Therapeutic …
-
As Pipeline Advances, Recursion Expands AI Focus to Clinical Trials
30 Jan 2025 20:57 GMT
… U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) has … AI powerhouse with a pipeline of more than 10 … model.
Also in the pipeline are about 10 advanced discovery … 2014 for certain blood cancers (Gilead Sciences’ Zydelig® [idelalisib], indicated in …
-
These 2 Dividend Stocks Are Absolute Bargains Right Now
08 Feb 2025 14:54 GMT
… medicines, led by its HIV products, continues to perform well. In … pandemic years.
And regarding its pipeline, Gilead Sciences is making progress on multiple … 3 studies. Some of Gilead Sciences' existing products, such as long-acting …
-
Is Exelixis a Biotech Stock Worth Adding to Your Portfolio?
28 Jan 2025 19:05 GMT
… is aggressively expanding its oncology portfolio with promising candidates like … its quality and diverse product offerings, expanding pipeline, strategic collaborations, and … Buy) or B (Buy) ratings: Gilead Sciences, Inc. (GILD), Jazz Pharmaceuticals plc …
-
Tuberculosis Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working In The Therapeutics Segment Delveinsight
23 Jan 2025 00:53 GMT
… .
Tuberculosis Pipeline: Late-Stage Products (Pre-registration)
7.
Tuberculosis Pipeline: Late-Stage Products (Phase … key fungal pneumonia companies, including Gilead Sciences, Astellas Pharma, Pfizer, Merck …
-
Hepatitis B Virus Pipeline Insights, Clinical Trials Assessment, Emerging Therapies and Companies | DelveInsight
20 Jan 2025 12:50 GMT
… the pipeline drug profiles, including clinical and nonclinical stage products. It … It further highlights the inactive pipeline products in this space.
Discover … Dong-A ST Co. Ltd., Gilead Sciences, Antios Therapeutics, Ascletis Pharmaceuticals, Shanghai …
-
Gilead Sciences: 2025 Preview, A Buy Thanks To Thriving HIV Franchise
29 Dec 2024 15:02 GMT
… thriving HIV business, promising oncology pipeline, and potential for long-term … The last time I covered Gilead Sciences (NASDAQ:GILD) for Seeking Alpha … sell ratings. It also provides product sales and forecasts for all …
-
Liver Cirrhosis Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 30+ Companies Working in the Domain
15 Jan 2025 18:00 GMT
… Therapeutics
6.
Liver Cirrhosis Pipeline: Late-Stage Products (Pre-registration)
7.
… Liver Cirrhosis Pipeline: Late-Stage Products (Phase III)
8.
Liver … Therapeutics, Inc., NGM Biopharmaceuticals, Inc., Gilead Sciences, Novo Nordisk A/S …
-
Crohn's Disease Market Report 2034: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA Approvals by DelveInsight
13 Jan 2025 12:53 GMT
… Tillotts Pharma (Zeria Pharmaceutical), Gilead Sciences and Galapagos NV, Boehringer … 's Disease pipeline products will significantly revolutionize the … Germany Healthcare Outlook | Biopsy Devices Pipeline Insight | Bacterial Conjunctivitis Market …
-
Nurix Therapeutics Outlines 2025 Goals and Objectives for Advancement of Its Robust Pipeline in Cancer and Autoimmune Diseases
13 Jan 2025 12:00 GMT
… diseases Advance our portfolio of partnered programs … chirally controlled drug product and select recommended … under collaboration agreements with Gilead Sciences, Inc., Sanofi S. … its collaborations and preclinical pipeline; the tolerability, safety …
About
© 1995-2025